Skip to main content
. 2021 Jul 30;100(30):e26431. doi: 10.1097/MD.0000000000026431

Table 6.

Pairwise comparison results from network meta-analysis on stroke.

Albiglutide 0.97 (0.7–1.35) 1.17 (0.85–1.63) 0.88 (0.63–1.24) 1.37 (0.93–2.03) 1.23 (0.85–1.79) 0.99 (0.71–1.38) 1 (0.71–1.4) 1.3 (0.84–2.02) 0.86 (0.39–1.9) 1.16 (0.88–1.52) 0.77 (0.51–1.17) 0.76 (0.44–1.29)
1.03 (0.74–1.43) Canagliflozin 1.21 (0.93–1.57) 0.91 (0.69–1.2) 1.41 (1–1.98) 1.27 (0.92–1.75) 1.02 (0.78–1.33) 1.03 (0.78–1.35) 1.34 (0.9–1.99) 0.89 (0.41–1.91) 1.2 (0.99–1.44) 0.79 (0.54–1.14) 0.78 (0.47–1.27)
0.85 (0.62–1.18) 0.83 (0.64–1.08) Dapagliflozin 0.75 (0.570.99) 1.17 (0.84–1.64) 1.05 (0.77–1.44) 0.84 (0.65–1.1) 0.85 (0.65–1.12) 1.11 (0.75–1.64) 0.73 (0.34–1.58) 0.99 (0.83–1.19) 0.65 (0.450.94) 0.64 (0.39–1.06)
1.13 (0.8–1.59) 1.1 (0.83–1.46) 1.33 (1.011.75) Dulaglutide 1.55 (1.092.2) 1.39 (1–1.94) 1.12 (0.84–1.49) 1.13 (0.85–1.52) 1.47 (0.98–2.21) 0.97 (0.45–2.12) 1.32 (1.071.62) 0.87 (0.59–1.27) 0.85 (0.51–1.42)
0.73 (0.49–1.08) 0.71 (0.51–1) 0.86 (0.61–1.2) 0.64 (0.450.92) Empagliflozin 0.9 (0.61–1.32) 0.72 (0.51–1.01) 0.73 (0.52–1.03) 0.95 (0.61–1.48) 0.62 (0.28–1.4) 0.85 (0.64–1.13) 0.56 (0.370.85) 0.55 (0.320.94)
0.81 (0.56–1.18) 0.79 (0.57–1.09) 0.95 (0.69–1.3) 0.72 (0.51–1) 1.11 (0.76–1.63) Ertugliflozin 0.8 (0.58–1.11) 0.81 (0.59–1.13) 1.06 (0.69–1.62) 0.7 (0.32–1.54) 0.94 (0.73–1.22) 0.62 (0.410.94) 0.61 (0.36–1.04)
1.01 (0.73–1.41) 0.98 (0.75–1.29) 1.19 (0.91–1.55) 0.89 (0.67–1.19) 1.39 (0.99–1.95) 1.25 (0.9–1.72) Exenatide 1.01 (0.77–1.34) 1.32 (0.89–1.96) 0.87 (0.4–1.88) 1.18 (0.97–1.43) 0.78 (0.54–1.13) 0.76 (0.47–1.25)
1 (0.71–1.4) 0.97 (0.74–1.28) 1.17 (0.89–1.54) 0.88 (0.66–1.18) 1.37 (0.97–1.94) 1.23 (0.89–1.7) 0.99 (0.75–1.31) Liraglutide 1.3 (0.87–1.94) 0.86 (0.4–1.86) 1.16 (0.95–1.42) 0.77 (0.53–1.12) 0.76 (0.46–1.24)
0.77 (0.49–1.19) 0.75 (0.5–1.11) 0.9 (0.61–1.33) 0.68 (0.45–1.02) 1.05 (0.67–1.64) 0.95 (0.62–1.46) 0.76 (0.51–1.13) 0.77 (0.52–1.15) Lixisenatide 0.66 (0.29–1.51) 0.89 (0.63–1.27) 0.59 (0.370.94) 0.58 (0.33–1.03)
1.17 (0.53–2.57) 1.13 (0.52–2.43) 1.37 (0.63–2.94) 1.03 (0.47–2.22) 1.6 (0.71–3.54) 1.43 (0.65–3.16) 1.15 (0.53–2.47) 1.17 (0.54–2.51) 1.52 (0.66–3.43) Osemaglutide 1.35 (0.64–2.84) 0.89 (0.39–2.01) 0.88 (0.37–2.12)
0.86 (0.66–1.13) 0.84 (0.69–1.01) 1.01 (0.84–1.21) 0.76 (0.620.93) 1.18 (0.89–1.56) 1.06 (0.82–1.37) 0.85 (0.7–1.03) 0.86 (0.7–1.05) 1.12 (0.79–1.59) 0.74 (0.35–1.56) Placebo 0.66 (0.480.91) 0.65 (0.41–1.03)
1.3 (0.86–1.98) 1.27 (0.87–1.84) 1.53 (1.062.21) 1.15 (0.79–1.69) 1.79 (1.172.74) 1.61 (1.072.41) 1.29 (0.89–1.87) 1.3 (0.89–1.9) 1.69 (1.062.71) 1.12 (0.5–2.53) 1.51 (1.12.08) Sotagliflozin 0.99 (0.56–1.72)
1.32 (0.78–2.27) 1.29 (0.79–2.11) 1.55 (0.95–2.55) 1.17 (0.71–1.94) 1.81 (1.063.14) 1.63 (0.96–2.75) 1.31 (0.8–2.15) 1.32 (0.8–2.19) 1.72 (0.97–3.06) 1.14 (0.47–2.74) 1.54 (0.97–2.44) 1.02 (0.58–1.78) Ssemaglutide